BTG1 expression correlates with the pathogenesis and progression of breast carcinomas
- 24 November 2013
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (4) , 3317-3326
Abstract
This study aimed to analyze the expression, clinical significance of B cell translocation gene 1 (BTG1) in breast carcinoma and the biological effect in its cell line by BTG1 overexpression. Immunohistochemistry and western blot were used to analyze BTG1 protein expression in 72 cases of breast cancer and 36 cases of normal tissues to study the relationship between BTG1 expression and clinical factors. Recombinant lentiviral vector was constructed to over-express EMP-1 and then infect breast cancer MCF-7 cell line. Quantitative real-time RT-PCR (qRT-PCR) and western blot were used to detect the mRNA level and protein of BTG1. MTT assay, cell apoptosis, cell cycles, migration and invasion assays were also conducted as to the influence of the upregulated expression of BTG1 that might be found on MCF-7 cells biological effect. The level of BTG1 protein expression was found to be significantly lower in breast cancer tissue than normal tissues (P P P MMP-9 protein expression compared with MCF-7 cell untransfected BTG1 (P MMP-9 protein expression, suggesting that BTG1 may play important roles as a negative regulator to breast cancer cell.Keywords
This publication has 20 references indexed in Scilit:
- BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosisOncology Reports, 2013
- Mitochondrial Biogenesis Drives Tumor Cell ProliferationThe American Journal of Pathology, 2011
- The mammalian anti‐proliferative BTG/Tob protein familyJournal of Cellular Physiology, 2009
- B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cellsMolecular Cancer Therapeutics, 2006
- Life and Death DecisionsScience, 2003
- The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family: Regulator in control of cell growth, differentiation, and DNA repair?Journal of Cellular Physiology, 2001
- BTG gene expression in the p53-dependent and -independent cellular response to DNA damageMolecular Carcinogenesis, 2000
- Overexpression of Cyclin E and Cyclin-Dependent Kinase Inhibitor (p27Kip1): Effect on Cell Cycle Regulation in HeLa CellsBiochemical and Biophysical Research Communications, 1997
- Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathwayNature Genetics, 1996
- Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene familyCell, 1991